ES8503512A1 - Complejos de prostaglandinas - Google Patents

Complejos de prostaglandinas

Info

Publication number
ES8503512A1
ES8503512A1 ES529483A ES529483A ES8503512A1 ES 8503512 A1 ES8503512 A1 ES 8503512A1 ES 529483 A ES529483 A ES 529483A ES 529483 A ES529483 A ES 529483A ES 8503512 A1 ES8503512 A1 ES 8503512A1
Authority
ES
Spain
Prior art keywords
complexes
prostaglandins
crosspovidone
dextrans
medicaments
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES529483A
Other languages
English (en)
Other versions
ES529483A0 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer AG
Original Assignee
Bayer AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE19833304867 external-priority patent/DE3304867A1/de
Priority claimed from DE19833304864 external-priority patent/DE3304864A1/de
Priority claimed from DE19833304880 external-priority patent/DE3304880A1/de
Application filed by Bayer AG filed Critical Bayer AG
Publication of ES8503512A1 publication Critical patent/ES8503512A1/es
Publication of ES529483A0 publication Critical patent/ES529483A0/es
Granted legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/58—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. poly[meth]acrylate, polyacrylamide, polystyrene, polyvinylpyrrolidone, polyvinylalcohol or polystyrene sulfonic acid resin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/61—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule the organic macromolecular compound being a polysaccharide or a derivative thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles

Landscapes

  • Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

PROCEDIMIENTO PARA LA PREPARACION DE FORMULACIONES ESTABLES DE COMPLEJOS DE PORTSGLANDINAS, DE FORMULA GENERAL (I).CONSISTE EN HACER REACCIONAR UNA SOLUCION DE PROSTAGLANDINA CON CROSSPOVIDONA, ALMIDON PRE-EMPASTADO O DEXTRANOS, EN UNA CANTIDAD TAL QUE LA RELACION PONDERAL DE PROSTAGLANDINA A CROSSPOVIDONA, ALMIDON PRE-EMPASTADO O DEXTRANOS, ESTE COMPRENDIDA ENTRE 1:1 Y 1:10.000. EL PRODUCTO OBTENIDO SE SECA CUIDADOSAMENTE EN UN TAMBOR DE VACIO.DE APLICACION EN EL TRATAMIENTO DE LA HIPERTENSION, EL ASMA BRONQUIAL, LAS ULCERAS GASTROINTESTINALES Y LAS TROMBOSIS.
ES529483A 1983-02-12 1984-02-06 Complejos de prostaglandinas Granted ES529483A0 (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE19833304867 DE3304867A1 (de) 1983-02-12 1983-02-12 Absorbate von prostaglandinen
DE19833304864 DE3304864A1 (de) 1983-02-12 1983-02-12 Adsorbate von prostaglandinen
DE19833304880 DE3304880A1 (de) 1983-02-12 1983-02-12 Adsorbate von prostaglandinen

Publications (2)

Publication Number Publication Date
ES8503512A1 true ES8503512A1 (es) 1985-03-01
ES529483A0 ES529483A0 (es) 1985-03-01

Family

ID=27190758

Family Applications (1)

Application Number Title Priority Date Filing Date
ES529483A Granted ES529483A0 (es) 1983-02-12 1984-02-06 Complejos de prostaglandinas

Country Status (14)

Country Link
US (1) US4675182A (es)
EP (1) EP0116358B1 (es)
KR (1) KR880002138B1 (es)
AU (1) AU572115B2 (es)
CA (1) CA1248524A (es)
DE (1) DE3470663D1 (es)
DK (1) DK61684A (es)
ES (1) ES529483A0 (es)
GR (1) GR79806B (es)
HU (1) HU196127B (es)
IE (1) IE56766B1 (es)
IL (1) IL70913A (es)
PH (1) PH25606A (es)
PT (1) PT78054B (es)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4681759A (en) * 1985-05-08 1987-07-21 Ortho Pharmaceutical Corporation Rioprostil-PVP complex
IE59361B1 (en) * 1986-01-24 1994-02-09 Akzo Nv Pharmaceutical preparation for obtaining a highly viscous hydrogel or suspension
JPH03220201A (ja) * 1988-11-18 1991-09-27 Eisai Co Ltd プロスタグランジン類と多糖類の結合体
AU8285991A (en) * 1990-07-26 1992-02-18 G.D. Searle & Co. Polymeric drug delivery system
US7289084B2 (en) 2005-02-22 2007-10-30 John Michael Lesniak Computer display apparatus
US8455547B2 (en) * 2008-02-05 2013-06-04 Allergan, Inc. Substituted cyclopentanes having prostaglandin activity
US7732443B2 (en) * 2008-03-18 2010-06-08 Yariv Donde Therapeutic substituted cyclopentanes
BRPI0912193A2 (pt) * 2008-05-09 2015-10-06 Allergan Inc compostos terapêuticos.

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3826823A (en) * 1972-09-25 1974-07-30 Syntex Inc Stabilized prostaglandin preparations
US4036954A (en) * 1973-11-02 1977-07-19 Yamanouchi Pharmaceutical Co., Ltd. Stable prostaglandin E group-containing formulation
IT1044797B (it) * 1974-10-15 1980-04-21 Ferruti Paolo Alti polimeri contenenti radicali prostaglandinici processo per la loro preparazione e loro impiego
DE2515001C2 (de) * 1975-04-04 1986-10-02 Schering AG, 1000 Berlin und 4709 Bergkamen Prostaglandin enthaltende gefriergetrocknete Pulver
AU524104B2 (en) * 1978-10-12 1982-09-02 Toray Industries, Inc. Stabilized prostaglandin e composition
SE431821B (sv) * 1979-01-29 1984-03-05 Perstorp Ab Lagringsstabilt, prostaglandininnehallande medicinskt preparat
US4211793A (en) * 1979-03-19 1980-07-08 American Cyanamid Company Triethyl citrate solutions of PGE-type compounds
US4301146A (en) * 1980-07-29 1981-11-17 G. D. Searle & Co. Stabilization of 16-oxygenated prostanoic acid derivatives
US4370348A (en) * 1981-06-03 1983-01-25 Ortho Pharmaceutical Corporation Method of inducing cytoprotection

Also Published As

Publication number Publication date
AU2428684A (en) 1984-08-16
HU196127B (en) 1988-10-28
AU572115B2 (en) 1988-05-05
PT78054B (en) 1986-03-20
IE56766B1 (en) 1991-12-04
GR79806B (es) 1984-10-31
KR850000391A (ko) 1985-02-27
EP0116358A1 (de) 1984-08-22
US4675182A (en) 1987-06-23
DK61684D0 (da) 1984-02-10
CA1248524A (en) 1989-01-10
ES529483A0 (es) 1985-03-01
PH25606A (en) 1991-08-08
DE3470663D1 (en) 1988-06-01
EP0116358B1 (de) 1988-04-27
DK61684A (da) 1984-08-13
IL70913A0 (en) 1984-05-31
PT78054A (en) 1984-03-01
KR880002138B1 (en) 1988-10-17
IL70913A (en) 1987-03-31
IE840313L (en) 1984-08-12

Similar Documents

Publication Publication Date Title
PH21386A (en) Platinum-diamine complexes, their pharmaceutical compositions and process for the preparation thereof
ATE22562T1 (de) 6-substituierte s-triazolo(3,4-a)phthalazinderivate.
ES8801243A1 (es) Procedimiento para la obtencion de medicamentos que contienen 1-heteroaril-4--aril-pirazolin-5-onas.
ZA796244B (en) New derivatives of 3-quinoline-carboxylic acid,process for preparing them,their use as a medicament and the pharmaceutical compositions containing them
IL73322A0 (en) Phenethylamine derivatives,their production and pharmaceutical compositions containing them
EP0006614A3 (en) Pyridyl- and imidazopyridyloxypropanolamines, process for preparing the same and pharmaceutical compositions containing the same
ZA843722B (en) Dibenzodiazepin derivatives,a process for their preparation and their use as medicaments
ES8503512A1 (es) Complejos de prostaglandinas
IL57229A (en) Hydroxypropyl-imidazole derivatives,their production and pharmaceutical compositions containing them
IL57785A (en) Imidazoquinoxalines and their salts,process for their preparation,their use as medicaments and the pharmaceutical compositions containing them
ZA79315B (en) Guanidine derivatives,processes for their production and pharmaceutical compositions containing them
NZ195666A (en) 4,5-unsaturated prostanoic acid derivatives pharmaceutical compositions
DE2965099D1 (en) Prostaglandin analogue triazole derivatives, processes for their preparation and a pharmaceutical composition containing them
IL56808A0 (en) 1-oxo-1h-pyrimido(6,1)benztheazole derivatives,process forthe preparation thereof and pharmaceutical compositions containing the same
DE3275087D1 (en) Benzamide derivatives, a process for preparing the same, and pharmaceutical compositions containing the same
PH15587A (en) N-phenylindoline derivatives,their production and pharmaceutical compositions containing them
GR80730B (en) 1,2-dithiolan derivatives, processes for their production, pharmaceutical compositions containing them and their use
ES8404693A1 (es) Procedimiento de preparacion de nuevos amino-14 esteroides.
ES8604731A1 (es) Un metodo de preparar derivados de 6,11-dihidrodibenz (b,e) oxepina
IL56696A0 (en) Nitroso-urea derivatives,their production and pharmaceutical compositions containing them
EP0257631A3 (en) Oxolabdanes, a process for their preparation and their use as medicaments
EP0145223A3 (en) Highly stable free iodine iodophor compositions, process for preparing same and process for using same
IL64449A0 (en) Imidazole derivatives,a process for the preparation thereof and pharmaceutical compositions containing them
IL56617A0 (en) Benzimidazole derivatives,their manufacture and pharmaceutical compositions containing
ZA791887B (en) New derivatives of (1-3)benzodioxine,a process for preparing them and the pharmaceutical compositions containing them